{"entity":{"id":"bracco","kind":"company","name":"Bracco (Bracco Imaging and Bracco Diagnostics)","aka":["Bracco Imaging","Bracco Diagnostics","Bracco Imaging S.p.A.","Bracco International"],"tldr":"Bracco makes contrast agents for MRI, CT, X-ray and ultrasound, including MultiHance, ProHance, Vueway, Isovue, Iomervu, Gastrografin, barium drinks and Lumason.","summary":"Drugs@FDA lists Bracco as sponsor of MultiHance (NDA 021357), ProHance (NDA 020131), Isovue (NDA 018735), Iomervu (NDA 216016), Gastrografin (NDA 011245), the barium sulfate products of NDA 208143 and Lumason (NDA 203684); it also markets Vueway (gadopiclenol). The EMA register names Bracco Imaging S.p.A. as holder of Vueway and Bracco International B.V. of SonoVue. Its FDA establishment registrations name Bracco Diagnostics Inc. of Princeton, New Jersey, as owner operator. Blue Earth Diagnostics, a separate record, is a Bracco company.","asOf":"2026-11-04","links":[{"label":"Drugs@FDA MultiHance","url":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021357"},{"label":"Drugs@FDA Lumason","url":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203684"},{"label":"EMA: Vueway","url":"https://www.ema.europa.eu/en/medicines/human/EPAR/vueway"}],"tags":["contrast-agents-gaps-2026-11"],"related":["blue-earth-diagnostics"],"cancers":[],"sections":["imaging"],"technologies":["gadolinium-based-contrast-agents","iodinated-contrast-media","ultrasound-contrast-agents"],"targets":[],"drugs":["gadobenate-dimeglumine","gadoteridol","gadopiclenol","iopamidol","iomeprol","diatrizoate","barium-sulfate","sulfur-hexafluoride-microspheres"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo contrast agent gap fill (Drugs@FDA, FDA labels, DailyMed, EMA register, WHO ATC index)","editedOn":"2026-11-04"},"hq":"Princeton, NJ (US owner operator)","country":"US","companyType":"imaging","investors":[],"funding":[]},"route":"/companies/bracco/","neighbours":{"company":[{"id":"blue-earth-diagnostics","kind":"company","name":"Blue Earth Diagnostics (Bracco)","route":"/companies/blue-earth-diagnostics/"}],"section":[{"id":"imaging","kind":"section","name":"Imaging","route":"/fronts/imaging/"}],"technology":[{"id":"gadolinium-based-contrast-agents","kind":"technology","name":"Gadolinium-based and other MRI contrast agents","route":"/technologies/gadolinium-based-contrast-agents/"},{"id":"iodinated-contrast-media","kind":"technology","name":"Iodinated and barium contrast for CT and X-ray","route":"/technologies/iodinated-contrast-media/"},{"id":"ultrasound-contrast-agents","kind":"technology","name":"Ultrasound contrast agents (microbubbles)","route":"/technologies/ultrasound-contrast-agents/"}],"drug":[{"id":"barium-sulfate","kind":"drug","name":"Barium sulfate oral contrast","route":"/drugs/barium-sulfate/"},{"id":"diatrizoate","kind":"drug","name":"Diatrizoate meglumine and diatrizoate sodium (oral contrast)","route":"/drugs/diatrizoate/"},{"id":"gadobenate-dimeglumine","kind":"drug","name":"Gadobenate dimeglumine","route":"/drugs/gadobenate-dimeglumine/"},{"id":"gadopiclenol","kind":"drug","name":"Gadopiclenol","route":"/drugs/gadopiclenol/"},{"id":"gadoteridol","kind":"drug","name":"Gadoteridol","route":"/drugs/gadoteridol/"},{"id":"iomeprol","kind":"drug","name":"Iomeprol","route":"/drugs/iomeprol/"},{"id":"iopamidol","kind":"drug","name":"Iopamidol","route":"/drugs/iopamidol/"},{"id":"sulfur-hexafluoride-microspheres","kind":"drug","name":"Sulfur hexafluoride microbubbles (ultrasound contrast)","route":"/drugs/sulfur-hexafluoride-microspheres/"}]}}